SageGuard Financial Group LLC Buys Shares of 147,445 Colgate-Palmolive Company $CL

SageGuard Financial Group LLC bought a new stake in Colgate-Palmolive Company (NYSE:CL) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 147,445 shares of the company’s stock, valued at approximately $11,651,000. Colgate-Palmolive comprises approximately 1.9% of SageGuard Financial Group LLC’s investment portfolio, making the stock its 17th biggest position.

Other large investors have also recently bought and sold shares of the company. ProShare Advisors LLC grew its position in shares of Colgate-Palmolive by 11.0% in the 3rd quarter. ProShare Advisors LLC now owns 2,047,542 shares of the company’s stock valued at $163,681,000 after buying an additional 202,379 shares during the last quarter. Providence Capital Advisors LLC acquired a new stake in shares of Colgate-Palmolive in the third quarter valued at about $5,373,000. Asset Management One Co. Ltd. increased its stake in shares of Colgate-Palmolive by 3.9% in the third quarter. Asset Management One Co. Ltd. now owns 422,292 shares of the company’s stock valued at $33,758,000 after buying an additional 16,017 shares during the period. Citigroup Inc. increased its stake in shares of Colgate-Palmolive by 43.7% in the third quarter. Citigroup Inc. now owns 1,346,590 shares of the company’s stock valued at $107,646,000 after buying an additional 409,710 shares during the period. Finally, TD Waterhouse Canada Inc. increased its stake in shares of Colgate-Palmolive by 248.5% in the third quarter. TD Waterhouse Canada Inc. now owns 87,410 shares of the company’s stock valued at $6,909,000 after buying an additional 62,327 shares during the period. 80.41% of the stock is currently owned by institutional investors.

Colgate-Palmolive Stock Performance

CL stock opened at $83.49 on Tuesday. The firm has a market cap of $66.98 billion, a PE ratio of 31.87, a price-to-earnings-growth ratio of 4.28 and a beta of 0.34. Colgate-Palmolive Company has a 1-year low of $74.54 and a 1-year high of $99.33. The company has a current ratio of 0.83, a quick ratio of 0.54 and a debt-to-equity ratio of 18.82. The stock has a 50-day moving average price of $89.78 and a 200-day moving average price of $83.81.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, January 30th. The company reported $0.95 EPS for the quarter, topping the consensus estimate of $0.91 by $0.04. The company had revenue of $5.23 billion during the quarter, compared to the consensus estimate of $5.13 billion. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The company’s quarterly revenue was up 5.8% on a year-over-year basis. During the same quarter last year, the firm posted $0.91 EPS. As a group, equities research analysts expect that Colgate-Palmolive Company will post 3.87 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Monday, April 20th will be given a dividend of $0.53 per share. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.52. The ex-dividend date of this dividend is Monday, April 20th. This represents a $2.12 annualized dividend and a dividend yield of 2.5%. Colgate-Palmolive’s payout ratio is 79.39%.

Insider Activity at Colgate-Palmolive

In other news, COO Panagiotis Tsourapas sold 15,000 shares of the stock in a transaction dated Thursday, February 12th. The shares were sold at an average price of $97.81, for a total transaction of $1,467,150.00. Following the transaction, the chief operating officer owned 10,415 shares of the company’s stock, valued at $1,018,691.15. This represents a 59.02% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Stanley J. Sutula III sold 97,843 shares of the stock in a transaction dated Wednesday, February 4th. The stock was sold at an average price of $94.27, for a total transaction of $9,223,659.61. Following the transaction, the chief financial officer directly owned 55,310 shares in the company, valued at $5,214,073.70. This trade represents a 63.89% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 184,683 shares of company stock worth $17,486,693. Corporate insiders own 0.43% of the company’s stock.

Analysts Set New Price Targets

CL has been the subject of several recent research reports. Citigroup increased their price target on Colgate-Palmolive from $95.00 to $105.00 and gave the company a “buy” rating in a research note on Monday, February 2nd. Barclays dropped their price target on shares of Colgate-Palmolive from $88.00 to $79.00 and set an “equal weight” rating on the stock in a research report on Tuesday, April 14th. Rothschild & Co Redburn set a $100.00 price target on shares of Colgate-Palmolive in a research report on Tuesday. Morgan Stanley boosted their price target on shares of Colgate-Palmolive from $87.00 to $100.00 and gave the stock an “overweight” rating in a research report on Monday, February 2nd. Finally, Deutsche Bank Aktiengesellschaft upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and boosted their price target for the stock from $90.00 to $98.00 in a research report on Monday, March 30th. Eleven investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $95.88.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.